Literature DB >> 26855517

Marital Status and Fertility in Adult Iranian Patients with β-Thalassemia Major.

Ghasem Miri-Aliabad1, Mahsoumeh Fadaee2, Ali Khajeh1, Majid Naderi1.   

Abstract

Expecting a family is an important component and a great goal for better quality of life for most of adults with β-thalassemia major. The aim of the present study was to examine the marital status of adults with β-thalassemia major. This cross-sectional study examined the marital status of patients with transfusion-dependent β-thalassemia aged over 15 years. Patients' demographic characteristics including age, gender, marital status, duration of marriage, divorce, having or not having children and spouse's health status were recorded. Information about the disease including cardiac and endocrine complications, ferritin level, splenectomy and viral hepatitis were also recorded. Of 228 patients with transfusion-dependent β-thalassemia major aged over 15 years who were treated at this medical center, 32 (14 %) were married. The mean age of married patients was 25.18 ± 4.74 years. Among the married patients, 8 (25 %) were females and 24 (75 %) patients were males. The mean age of marriage was 22.76 ± 4.16 years. The minimum and maximum marriage age was 15 and 33 years, respectively. The median duration of marriage was one year with the range from 3 months to 11 years. Only 8 (25 %) patients (one female and seven males) had children. Therapeutic advances have led to significantly increased survival and improved quality of life and fertility of patients with β-thalassemia major. According to the results, 14 % of patients over 15 years were married which was slightly higher as compared with other similar studies.

Entities:  

Keywords:  Iron chelation; Marital status; Thalassemia major

Year:  2015        PMID: 26855517      PMCID: PMC4733684          DOI: 10.1007/s12288-015-0510-9

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  19 in total

1.  Reversible hypogonadotrophic hypogonadism in sexually infantile male thalassaemic patients with transfusional iron overload.

Authors:  R Chatterjee; M Katz
Journal:  Clin Endocrinol (Oxf)       Date:  2000-07       Impact factor: 3.478

2.  2003 William Allan Award address. The Thalassemias: the role of molecular genetics in an evolving global health problem.

Authors:  David Weatherall
Journal:  Am J Hum Genet       Date:  2004-03       Impact factor: 11.025

3.  Survival of medically treated thalassemia patients in Cyprus. Trends and risk factors over the period 1980-2004.

Authors:  Paul Telfer; Pietro G Coen; Soteroula Christou; Michael Hadjigavriel; Anita Kolnakou; Evangelia Pangalou; Nicos Pavlides; Michael Psiloines; Krikor Simamonian; Georghios Skordos; Maria Sitarou; Michael Angastiniotis
Journal:  Haematologica       Date:  2006-09       Impact factor: 9.941

4.  Pregnancy in patients with beta-thalassaemia major: maternal and foetal outcome.

Authors:  Alfredo Mancuso; Annamaria Giacobbe; Antonio De Vivo; Francesca Venera Ardita; Anna Meo
Journal:  Acta Haematol       Date:  2008-01-10       Impact factor: 2.195

5.  Beta-thalassemia major and successful pregnancy.

Authors:  R M Kumar; D E Rizk; A Khuranna
Journal:  J Reprod Med       Date:  1997-05       Impact factor: 0.142

Review 6.  Update on thalassemia: clinical care and complications.

Authors:  Melody J Cunningham
Journal:  Hematol Oncol Clin North Am       Date:  2010-02       Impact factor: 3.722

7.  Marriage and child bearing in patients with transfusion-dependent thalassemia major.

Authors:  Mandana Zafari; Mehrnoush Kosaryan
Journal:  J Obstet Gynaecol Res       Date:  2014-08       Impact factor: 1.730

8.  Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine.

Authors:  Caterina Borgna-Pignatti; Simone Rugolotto; Piero De Stefano; Huaqing Zhao; Maria Domenica Cappellini; Giovanni Carlo Del Vecchio; Maria Antonietta Romeo; Gian Luca Forni; Maria Rita Gamberini; Roberta Ghilardi; Antonio Piga; Avital Cnaan
Journal:  Haematologica       Date:  2004-10       Impact factor: 9.941

9.  Global epidemiology of hemoglobin disorders.

Authors:  M Angastiniotis; B Modell
Journal:  Ann N Y Acad Sci       Date:  1998-06-30       Impact factor: 5.691

Review 10.  What is new in iron overload?

Authors:  Christiane Vermylen
Journal:  Eur J Pediatr       Date:  2007-09-26       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.